Bernstein upgrades J&J, says valuation is 'historically cheap'


Amid Johnson & Johnson's legal battles the worst case is already priced into the stock and it's now a buy, according to Bernstein.

More In Pro News and Analysis

CNBC ProUBS put out the definitive guide for investing under a Biden administration
CNBC ProThe set-up is 'attractive' for these stocks heading into earnings, analysts say
CNBC ProStock investors beware: There can be too much of a good thing